Roivant Sciences (ROIV) director sells 17,750 shares after exercising options
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Roivant Sciences Ltd. director Melissa B. Epperly exercised stock options and sold shares of the company on June 29, 2026. She exercised options to acquire 17,750 Common Shares at an exercise price of $4.46 per share, increasing her direct common share holdings before subsequent sales.
That same day, she executed open-market sales totaling 17,750 Common Shares in two transactions: 2,748 shares at a weighted average price of $34.71 and 15,002 shares at a weighted average price of $34.32. The footnotes state these were filled across multiple trades within price ranges from $33.65 to $34.80. After the transactions, Epperly directly held 16,474 Common Shares and 169,166 stock options to purchase additional shares, with the option grant exercised here fully vested and expiring on July 19, 2032.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Net Seller: 17,750 shares ($610,252)
Net Sell
4 txns
Insider
Epperly Melissa B,
Role
null
Sold
17,750 shs ($610K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) | 17,750 | $0.00 | -- |
| Exercise | Common Shares | 17,750 | $4.46 | $79K |
| Sale | Common Shares | 15,002 | $34.32 | $515K |
| Sale | Common Shares | 2,748 | $34.71 | $95K |
Holdings After Transaction:
Stock Option (Right to Buy) — 169,166 shares (Direct, null);
Common Shares — 34,224 shares (Direct, null)
Footnotes (1)
- The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.65 to $34.64, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.65 to $34.80, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range. Reflects an award of stock options to purchase Common Shares that is fully vested.
Key Figures
Shares sold: 17,750 shares
Weighted average sale price (lot 1): $34.71/share
Weighted average sale price (lot 2): $34.32/share
+5 more
8 metrics
Shares sold
17,750 shares
Total Common Shares sold in open-market transactions on June 29, 2026
Weighted average sale price (lot 1)
$34.71/share
2,748 Common Shares sold in one transaction
Weighted average sale price (lot 2)
$34.32/share
15,002 Common Shares sold in another transaction
Options exercised
17,750 shares
Stock options converted into Common Shares on June 29, 2026
Option exercise price
$4.46/share
Strike price for exercised stock options
Shares held after
16,474 shares
Direct Common Share holdings following the reported transactions
Options held after
169,166 options
Direct stock option holdings after the derivative transaction
Option expiration
July 19, 2032
Expiration date of the stock option award exercised in part
Key Terms
open-market sale, Stock Option (Right to Buy), weighted average price, fully vested, +1 more
5 terms
open-market sale financial
"transaction_action": "open-market sale""
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
Stock Option (Right to Buy) financial
"security_title": "Stock Option (Right to Buy)""
weighted average price financial
"The price reported in column 4 is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
fully vested financial
"Reflects an award of stock options to purchase Common Shares that is fully vested."
derivative exercise/conversion financial
"transaction_action": "derivative exercise/conversion""
FAQ
What insider transactions did Roivant Sciences (ROIV) director Melissa Epperly report?
Melissa Epperly reported exercising options for 17,750 Roivant Sciences Common Shares and selling 17,750 shares in open-market transactions on June 29, 2026. These actions combined an option exercise with same-day share sales, a common liquidity pattern for insiders managing equity compensation.
What stock options did Melissa Epperly exercise in Roivant Sciences (ROIV)?
Epperly exercised fully vested stock options covering 17,750 Common Shares at an exercise price of $4.46 per share. The underlying option award is described as expiring on July 19, 2032, and is recorded as a direct holding of stock options following the transaction.
What is the nature of Melissa Epperly’s Roivant Sciences (ROIV) ownership after the Form 4 transactions?
All reported holdings are classified as directly owned. After exercising options and selling shares, Epperly holds 16,474 Common Shares directly and 169,166 directly owned stock options, according to the post-transaction share and option balances listed in the Form 4 data.